Nivolumab Combined With BMS-986253 in HCC Patients

Clinical trial NCT04050462 · TERMINATED

Trial details

NCT number: NCT04050462
Sponsor: NYU Langone Health
Status: TERMINATED
Phase: Phase 2
Study type: INTERVENTIONAL

Hepatocellular Carcinoma

Start date: 2019-09-12
Primary completion: 2025-01-31
Enrollment: 13

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.